MyBiotech is a CDMO on the fields of Biotechnology and Pharmaceuticals.
Biotechnological production is covered with all aspects of upstream and downstream processes focusing on cell disruption with our propriety technology and purification with chromatographic methods such as ion exchange and supercritical fluid chromatography. Biotechnological production of active pharmaceutical ingredients and natural substances is also one of the core aspects of our business. Our products include Algae derived Omega-3 fatty acids, innovative Omega-3 formulations Curcumin, Phycocyanin along with plant derived natural supplements.
Pharmaceutical division is specialized on development and technology transfer of nanoparticle and microparticle formulations from concept through development all the way up to GMP manufacturing. We are continuously developing and adapting innovative production methods for GMP manufacturing and processing of particulate systems. We support you with our innovative technologies to bring your project one step closer to success.
Daniel is the CEO and Co-founder of MyBiotech GmbH. He holds a PhD degree in Biotechnology from University of Saarland, Germany. He held several leading positions in biotech and pharma industry, where he was working in GLP-certified environment for project development in collaboration with big pharma and biotech companies. Furthermore, he has gained experience in biotech business development for sales and marketing activities for leading biotech and pharma companies across Europe. He played a major role for managing the merger with MJR PharmJet in 2020 to widen the company horizon and extend its service and product portfolio to the pharma business.
Emre is the CSO of MyBiotech. He holds a PhD degree in Pharmaceutical Technology from Johannes Gutenberg University in Mainz, Germany. He is an internationally recognized scientist with more than 15 years of international research and development experience, as well as executive management experience in the pharmaceutical industry. He was the CEO and co-founder of former MJR Pharmjet. He has held management positions in various pharmaceutical companies. His expertise is on drug delivery systems, nanoparticle development and production method development in pharmaceutical industrial environment with strong focus on GMP compliance.
Nazende is the head of R&D Pharma and responsible for the design, management and evaluation of pharma research activities and projects. She received her PhD in Biopharmaceutics and Pharmaceutical Technology from the University of Saarland, Germany. She is an acknowledged scientific manager with over 15 years of R&D experience at leading positions of international pharmaceutical companies. She has already coordinated and participated various international and national projects as principal investigator and project manager. She brings extensive GMP operations knowledge to MyBiotech, as well as solid know-how on innovative nano drug delivery systems.
Daniela is the head of R&D Biotech and responsible for biotechnological projects with a focus on the biotechnological production and purification of Omega-3 fatty acids. She received her PhD in biotechnology from the University of Saarland, Germany. Daniela has vast experience in management of biotechnological projects and scientific education, as well as research and customer project management. Furthermore, she leaded a cell culture lab in a GMP and GLP certified international contract research organisation. At MyBiotech Daniela is responsible for the complete aspects of biotechnological processes.
Petra is the head of Product Development Pharma and responsible for the implementation of product development projects with a special focus on micro- and nanoparticles for pharmaceutical applications. She is graduated as Pharmacist from University of Saarland, Germany. She has 30 years of experience in pharmaceutical industry where has held leading positions in manufacturing and development of pharmaceuticals. She has extensive knowledge on conventional production methods, as well as novel methods required for the production of nano and micro particles. At MyBiotech Petra is responsible for technology transfer from lab-scale through pilot scale up to commercial scale.
Felix is the head of production and is responsible for all technical aspects and the development of innovative production equipment and processes. He holds a degree in Mechanical Engineering from the Trier University of Applied Sciences, Germany, as well as Electronics and Computer Science degree. He has more than 10 years of experience in plant and device construction and processing plant development. He is the inventor of several patents including micro-reaction processes, design and sophisticated measurement devices. At MyBiotech he has a special focus on establishment of continuous manufacturing methods and their application in pharmaceuticals and biotechnology.
Merger of MyBiotech and MJR PharmJet under the roof of MyBiotech GmbH
Foundation of the MyBiotech GmbH
Expansion, purchase and conversion of the Überherrn industrial campus, relocation
Foundation of Instillo GmbH; re-organization and transfer of administrative tasks and IP rights
Patenting of MJR-based processes in the pharmaceutical field
Application of MJR in the pharmaceutical sector by Dr. Emre Türeli, foundation of MJR PharmJet GmbH, Starterzentrum Homburg
Invention of the MicroJet Reactor (MJR) by Dr. Bernd Penth